# Justin Bekelman

> Justin Bekelman is the co-founder and CEO of Daymark Health, a Philadelphia-based value-based oncology company building a tech-enabled medical group that wraps clinical, mental health, and social support around people facing cancer. A radiation oncologist with roughly 200 published research articles, he spent two decades at the University of Pennsylvania, where he founded the Penn Center for Cancer Care Innovation at the Abramson Cancer Center before leaving to build a company that contracts directly with health plans to take on total cost of care. Daymark launched publicly in 2025 with $11.5M in seed funding and closed a $20M Series A in September 2025.

- **Role:** Co-founder and CEO at Daymark Health
- **Organizations:** Daymark Health, University of Pennsylvania (Perelman School of Medicine), Penn Center for Cancer Care Innovation, Abramson Cancer Center, Leonard Davis Institute for Health Economics, National Cancer Policy Forum
- **Nationality:** American
- **Education:** AB, Magna Cum Laude, Princeton University (Woodrow Wilson School / School of Public and International Affairs), MD, Yale School of Medicine, Internship, Internal Medicine, Johns Hopkins University, Residency, Radiation Oncology (Chief Resident), Memorial Sloan Kettering Cancer Center
- **Known for:** Authored nearly 200 peer-reviewed research articles, Founding Director of the Penn Center for Cancer Care Innovation at the Abramson Cancer Center, Elected member of the American Society for Clinical Investigation

## Career timeline

- **2003** — Earned MD from Yale School of Medicine
- **2008** — Completed radiation oncology residency at Memorial Sloan Kettering Cancer Center, serving as Chief Resident
- **—** — Joined University of Pennsylvania faculty; became Marietta and Howard Stoeckel Professor of Radiation Oncology, Medicine, and Medical Ethics and Health Policy
- **—** — Served as Special Assistant to the Under Secretary of Defense, U.S. Department of Defense
- **—** — Founded and directed the Penn Center for Cancer Care Innovation at the Abramson Cancer Center
- **2023** — Named to the National Cancer Policy Forum of the National Academies
- **2024** — Co-founded Daymark Health
- **2025-04** — Daymark Health launched publicly with $11.5M seed funding co-led by Maverick Ventures and Yosemite
- **2025-09** — Daymark Health closed $20M Series A led by Healthier Capital and Blue Venture Fund

## Achievements

- Authored nearly 200 peer-reviewed research articles
- Founding Director of the Penn Center for Cancer Care Innovation at the Abramson Cancer Center
- Elected member of the American Society for Clinical Investigation
- Appointed to the National Cancer Policy Forum (2023)
- Led large-scale research programs funded by the National Cancer Institute and the Patient-Centered Outcomes Research Institute
- Co-founded and scaled Daymark Health to serve 2,500+ cancer patients within its first year
- Raised $31.5M total across seed and Series A rounds for Daymark Health

## Latest updates

- **2025-09** — Daymark Health closed a $20M Series A led by Healthier Capital and Blue Venture Fund to scale its value-based cancer care platform nationally.
- **2025-04** — Daymark Health publicly launched with $11.5M in seed funding and a partnership with a leading Northeast health plan, serving 2,500+ patients.
- **2026-03** — Daymark Health expanded its clinical advisory board as it grew its value-based oncology offering.

## Links

- Website: https://daymarkhealth.com
- LinkedIn: https://www.linkedin.com/in/bekelman/

---

Profile page: https://yespress.io/justin-bekelman
Published by YesPress — https://yespress.io
Last updated: 2026-06-11